Daniel Plosky, MD
Otolaryngology · Springfield, MANPI 1093999484
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $815 of the $1,358 with a category attached, or 60.1%. Inspire Medical Systems, Inc. accounts for 63.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $838 and has fallen 84.0% since, to $134 in 2025.
Across 14 payments — averaging $96.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$866
- Intersect ENT, Inc.$206
- Sanofi-aventis U.S. LLC$121
- Smith+Nephew$45
- Sanofi$45
- Optinose US, Inc.$27
- plus $48 from 2 others
What the payments were for
- Travel & lodging$81560%
- Food & beverage$44333%
- Education$997%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $866 |
| Intersect ENT, Inc. | 3 | $206 |
| Sanofi-aventis U.S. LLC | 2 | $121 |
| Smith+Nephew | 1 | $45 |
| Sanofi | 3 | $45 |
| Optinose US, Inc. | 1 | $27 |
| Acclarent, Inc | 1 | $26 |
| Amgen | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,358 in reported general payments places this provider in the 65th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 11 | $2,720 |
| Ipratropium Bromide | 52 | $1,817 |
| Fluocinolone Acetonide Oil | 13 | $1,094 |
| Ofloxacin | 21 | $920 |
| Fluticasone Propionate | 21 | $530 |
| Nystatin | 19 | $502 |
| Azelastine Hcl | 12 | $279 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $121 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Springfield
- Theodore MasonSpringfield$4K
- Ayesha KhalidConcord$511K
- Dennis PoeBoston$264K
- Peter WeberBoston$157K
- Kevin EmerickBoston$89K
- Benjamin BleierBoston$77K
- Gregory RandolphBoston$56K
- Daniel LeeBoston$52K
- Pratik PradhanBrockton$51K
- Marika RussellBoston$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.